Has Iyad Hamarneh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $855,483 in general payments to Iyad Hamarneh, MD across 602 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Iyad Hamarneh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Iyad Hamarneh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Iyad Hamarneh, MD

Medical Oncology · Prescott, AZNPI 1427268259

Payments from drug & device makers

$855,483in general payments, 2019–2025

Across 602 payments — averaging $1421.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$481K
AstraZeneca$165K
Eli Lilly$158K
Genentech, Inc.$31K
Gilead$9K
Pfizer$7K
plus $5K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	281	$481,159
AstraZeneca	28	$164,972
Eli Lilly	5	$157,569
Genentech, Inc.	4	$30,900
Gilead(2 entities)	21	$9,270
Pfizer	40	$6,728
Seagen Inc.	9	$390
Sanofi	9	$355
E.r. Squibb & Sons, L.L.C.	21	$338
Johnson & Johnson	12	$312
Merck	17	$296
Bristol Myers Squibb	13	$288
Genmab U.S., Inc.	11	$286
Amgen	15	$262
AbbVie	10	$224
Novartis	12	$192
Genentech USA, Inc.	10	$170
Array Biopharma Inc	7	$115
AVEO Pharmaceuticals, Inc.	1	$99
Eisai Inc.	5	$94
Servier Pharmaceuticals LLC	4	$89
Stemline Therapeutics Inc.	3	$86
Incyte Corporation	4	$84
Puma Biotechnology, Inc.	4	$82
Astellas Pharma US Inc	4	$81
Ipsen Biopharmaceuticals, Inc	4	$80
Boehringer Ingelheim	4	$74
Sobi, Inc	1	$70
GSK	4	$70
Bayer	4	$63
Mirati Therapeutics, Inc.	4	$62
Rigel Pharmaceuticals, Inc.	2	$56
Lilly USA, LLC	3	$55
Pharmacosmos Therapeutics Inc.	2	$52
EMD Serono, Inc.	3	$51
Lexicon Pharmaceuticals, Inc.	2	$42
Blueprint Medicines Corporation	2	$42
Karyopharm Therapeutics Inc.	2	$27
Boston Scientific	1	$26
Telix Pharmaceuticals	1	$25
Takeda Pharmaceuticals U.S.A., Inc.	1	$24
Beone Medicines USA, Inc.	1	$23
ADC Therapeutics America, Inc.	1	$23
Pharmacyclics LLC, An Abbvie Company	1	$21
Agios Pharmaceuticals, Inc.	1	$21
Beigene USA, Inc.	1	$20
Taiho Oncology, Inc.	1	$20
Immunogen, Inc.	1	$19
Springworks Therapeutics, Inc.	1	$18
Progenics Pharmaceuticals, Inc.	1	$17
Foundation Medicine, Inc.	1	$16
Regeneron Healthcare Solutions, Inc.	1	$14
Secura Bio, Inc.	1	$13

How this compares

$855,483 in reported general payments places this provider in the 90th percentile of 59 medical oncology providers in Arizona.

See all medical oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$10,444,446

Medicare patients

1,179

Services billed

374,180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Prescott

Allan Espinosa MorazanPrescott$1.1M
Michael BookmanTucson$4.8M
Erkut BorazanciScottsdale$3.5M
Daniel von HoffScottsdale$2.5M
Jason SalganickPhoenix$1.6M
Isaac BowmanGilbert$844K
Saba RadhiGilbert$540K
Roopesh KantalaMesa$491K
Mital PatelPhoenix$484K
Sarah ConlonFlagstaff$408K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →